Prognostic Stage IIA Breast Cancer AJCC v8 Completed Phase 2 Trials for Anastrozole (DB01217)

Also known as: Prognostic Stage 2A Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109633 (Prognostic Stage IIA Breast Cancer AJCC v8)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04294225Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast CancerTreatment